CMBA
MEDP icon

C.M. Bidwell & Associates’s Medpace MEDP Stock Holding History

C.M. Bidwell & Associates’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-151
Closed -$72.5K – 526
2026
Q1 		$72.5K Sell
151
-50
-25% -$25.6K 0.03% 190
2025
Q4 		$113K Hold
201
– – 0.05% 173
2025
Q3 		$103K Hold
201
– – 0.05% 177
2025
Q2 		$63.1K Hold
201
– – 0.03% 211
2025
Q1 		$61.2K Sell
201
-7
-3% -$2.35K 0.04% 203
2024
Q4 		$69.1K Hold
208
– – 0.04% 210
2024
Q3 		$69.4K Sell
208
-37
-15% -$14.1K 0.04% 208
2024
Q2 		$101K Hold
245
– – 0.07% 173
2024
Q1 		$99K Sell
245
-1
-0.4% -$352 0.07% 174
2023
Q4 		$75.4K Buy
246
+87
+55% +$23.5K 0.06% 188
2023
Q3 		$38.5K Hold
159
– – 0.03% 296
2023
Q2 		$38.2K Buy
+159
New +$33K 0.03% 310
2021
Q2 		– Sell
-406
Closed -$67K – 601
2021
Q1 		$67K Sell
406
-20
-5% -$3.06K 0.05% 275
2020
Q4 		$59K Sell
426
-98
-19% -$12.4K 0.05% 272
2020
Q3 		$59K Sell
524
-171
-25% -$19.8K 0.05% 246
2020
Q2 		$65K Sell
695
-2,615
-79% -$223K 0.06% 235
2020
Q1 		$243K Buy
3,310
+2,500
+309% +$217K 0.26% 101
2019
Q4 		$68K Sell
810
-915
-53% -$70.8K 0.06% 205
2019
Q3 		$145K Buy
+1,725
New +$130K 0.14% 158

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

C.M. Bidwell & Associates's MEDP Position: Q2 2026 in Review

C.M. Bidwell & Associates sold out of Medpace (MEDP) in Q2 2026, closing a stake of 151 shares — an estimated $72.5K sold.

C.M. Bidwell & Associates first reported a position in MEDP in Q3 2019 and held it in 19 quarters. The position peaked at $243K in Q1 2020. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • C.M. Bidwell & Associates reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 151 Medpace shares in Q2 2026, an estimated $72.5K.
  • C.M. Bidwell & Associates first reported a position in Medpace in Q3 2019 and held it in 19 quarters.
  • C.M. Bidwell & Associates's Medpace position peaked at $243K in Q1 2020.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.